Q9UHX3 (EMR2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 114.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: EGF-like module-containing mucin-like hormone receptor-like 2 Alternative name(s): EGF-like module receptor 2 CD_antigen=CD312 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 823 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor probably involved in cell attachment. |
| Subunit structure | Forms a heterodimer, consisting of a large extracellular region non-covalently linked to a seven-transmembrane moiety. Interacts with chondroitin sulfate. Ref.5 Ref.7 |
| Subcellular location | |
| Tissue specificity | Expression is restricted to myeloid cells. Highest expression was found in peripheral blood leukocytes, followed by spleen and lymph nodes, with intermediate to low levels in thymus, bone marrow, fetal liver, placenta, and lung, and no expression in heart, brain, skeletal muscle, kidney, or pancreas. Expression is also detected in monocyte/macrophage and Jurkat cell lines but not in other cell lines tested. Ref.1 Ref.6 |
| Domain | The GPS domain is necessary, but not sufficient for receptor cleavage, which require the entire extracellular stalk. Binding to chondroitin sulfate is mediated by the fourth EGF domain. |
| Post-translational modification | Autoproteolytically cleaved into 2 subunits, an extracellular alpha subunit and a seven-transmembrane beta subunit. Ref.4 Ref.7 |
| Sequence similarities | Belongs to the G-protein coupled receptor 2 family. LN-TM7 subfamily. Contains 5 EGF-like domains. Contains 1 GPS domain. |
| Sequence caution | The sequence BAC06146.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell adhesion |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | EGF-like domain Repeat Signal Transmembrane Transmembrane helix |
| Ligand | Calcium |
| Molecular function | G-protein coupled receptor Receptor Transducer |
| PTM | Autocatalytic cleavage Disulfide bond Glycoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | cell adhesion Inferred from electronic annotation. Source: UniProtKB-KW neuropeptide signaling pathwayInferred from electronic annotation. Source: InterPro |
| Cellular component | integral to membrane Traceable author statement. Source: GDB plasma membraneTraceable author statement. Source: Reactome |
| Molecular function | G-protein coupled receptor activity Traceable author statement. Source: GDB calcium ion bindingInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] Note: A number of isoforms are probably produced. A soluble form due to a frameshift which introduced a stop codon immediately before the first TM domain is also detected. | ||||||
| Isoform 1 (identifier: Q9UHX3-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UHX3-2) The sequence of this isoform differs from the canonical sequence as follows: 397-407: Missing. | ||||||
| Isoform 3 (identifier: Q9UHX3-3) The sequence of this isoform differs from the canonical sequence as follows: 163-211: Missing. | ||||||
| Isoform 4 (identifier: Q9UHX3-4) The sequence of this isoform differs from the canonical sequence as follows: 119-211: Missing. | ||||||
| Isoform 5 (identifier: Q9UHX3-5) The sequence of this isoform differs from the canonical sequence as follows: 119-260: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | Potential | |||||||||||||||||||||||||||
| Chain | 24 – 823 | 800 | EGF-like module-containing mucin-like hormone receptor-like 2 | PRO_0000012875 | ||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||
| Topological domain | 24 – 540 | 517 | Extracellular Potential | |||||||||||||||||||||||||||
| Transmembrane | 541 – 561 | 21 | Helical; Name=1; Potential | |||||||||||||||||||||||||||
| Topological domain | 562 – 569 | 8 | Cytoplasmic Potential | |||||||||||||||||||||||||||
| Transmembrane | 570 – 590 | 21 | Helical; Name=2; Potential | |||||||||||||||||||||||||||
| Topological domain | 591 – 605 | 15 | Extracellular Potential | |||||||||||||||||||||||||||
| Transmembrane | 606 – 626 | 21 | Helical; Name=3; Potential | |||||||||||||||||||||||||||
| Topological domain | 627 – 644 | 18 | Cytoplasmic Potential | |||||||||||||||||||||||||||
| Transmembrane | 645 – 665 | 21 | Helical; Name=4; Potential | |||||||||||||||||||||||||||
| Topological domain | 666 – 683 | 18 | Extracellular Potential | |||||||||||||||||||||||||||
| Transmembrane | 684 – 704 | 21 | Helical; Name=5; Potential | |||||||||||||||||||||||||||
| Topological domain | 705 – 735 | 31 | Cytoplasmic Potential | |||||||||||||||||||||||||||
| Transmembrane | 736 – 756 | 21 | Helical; Name=6; Potential | |||||||||||||||||||||||||||
| Topological domain | 757 – 760 | 4 | Extracellular Potential | |||||||||||||||||||||||||||
| Transmembrane | 761 – 781 | 21 | Helical; Name=7; Potential | |||||||||||||||||||||||||||
| Topological domain | 782 – 823 | 42 | Cytoplasmic Potential | |||||||||||||||||||||||||||
| Domain | 25 – 66 | 42 | EGF-like 1 | |||||||||||||||||||||||||||
| Domain | 67 – 118 | 52 | EGF-like 2; calcium-binding | |||||||||||||||||||||||||||
| Domain | 119 – 162 | 44 | EGF-like 3; calcium-binding | |||||||||||||||||||||||||||
| Domain | 163 – 211 | 49 | EGF-like 4; calcium-binding Potential | |||||||||||||||||||||||||||
| Domain | 212 – 260 | 49 | EGF-like 5; calcium-binding Potential | |||||||||||||||||||||||||||
| Domain | 479 – 529 | 51 | GPS | |||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||
| Site | 517 – 518 | 2 | Cleavage | |||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||
| Glycosylation | 41 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 111 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 206 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 298 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 347 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 354 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 456 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Glycosylation | 460 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||
| Disulfide bond | 29 ↔ 39 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 33 ↔ 45 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 47 ↔ 65 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 71 ↔ 85 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 79 ↔ 94 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 96 ↔ 117 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 123 ↔ 136 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 130 ↔ 145 | Ref.8 | ||||||||||||||||||||||||||||
| Disulfide bond | 147 ↔ 161 | By similarity | ||||||||||||||||||||||||||||
| Disulfide bond | 167 ↔ 180 | By similarity | ||||||||||||||||||||||||||||
| Disulfide bond | 174 ↔ 189 | By similarity | ||||||||||||||||||||||||||||
| Disulfide bond | 191 ↔ 210 | By similarity | ||||||||||||||||||||||||||||
| Disulfide bond | 216 ↔ 229 | By similarity | ||||||||||||||||||||||||||||
| Disulfide bond | 223 ↔ 238 | By similarity | ||||||||||||||||||||||||||||
| Disulfide bond | 240 ↔ 259 | By similarity | ||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||
| Alternative sequence | 119 – 260 | 142 | Missing in isoform 5. | VSP_041364 | ||||||||||||||||||||||||||
| Alternative sequence | 119 – 211 | 93 | Missing in isoform 4. | VSP_041365 | ||||||||||||||||||||||||||
| Alternative sequence | 163 – 211 | 49 | Missing in isoform 3. | VSP_041366 | ||||||||||||||||||||||||||
| Alternative sequence | 397 – 407 | 11 | Missing in isoform 2. | VSP_041367 | ||||||||||||||||||||||||||
| Natural variant | 314 | 1 | A → V. Corresponds to variant rs35612307 [ dbSNP | Ensembl ]. | VAR_061229 | ||||||||||||||||||||||||||
| Natural variant | 605 | 1 | T → I. Corresponds to variant rs4410209 [ dbSNP | Ensembl ]. | VAR_026719 | ||||||||||||||||||||||||||
| Natural variant | 614 | 1 | L → F. Ref.1 Ref.3 Corresponds to variant rs2524383 [ dbSNP | Ensembl ]. | VAR_026720 | ||||||||||||||||||||||||||
| Natural variant | 665 | 1 | S → F. Corresponds to variant rs3752187 [ dbSNP | Ensembl ]. | VAR_026721 | ||||||||||||||||||||||||||
| Natural variant | 720 | 1 | E → D. Corresponds to variant rs57865820 [ dbSNP | Ensembl ]. | VAR_061230 | ||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||
| Mutagenesis | 518 | 1 | S → A: Abolishes cleavage. Ref.4 | |||||||||||||||||||||||||||
| Sequence conflict | 531 | 1 | Missing in AAC05172. Ref.3 | |||||||||||||||||||||||||||
| Sequence conflict | 823 | 1 | N → R in BAC06146. Ref.2 | |||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||
| Beta strand | 37 – 43 | 7 | ||||||||||||||||||||||||||||
| Beta strand | 45 – 47 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 54 – 58 | 5 | ||||||||||||||||||||||||||||
| Helix | 70 – 72 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 83 – 87 | 5 | ||||||||||||||||||||||||||||
| Beta strand | 92 – 96 | 5 | ||||||||||||||||||||||||||||
| Beta strand | 109 – 111 | 3 | ||||||||||||||||||||||||||||
| Helix | 112 – 114 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 227 – 231 | 5 | ||||||||||||||||||||||||||||
| Beta strand | 236 – 239 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 252 – 254 | 3 | ||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97." Lin H.-H., Stacey M., Hamann J., Gordon S., McKnight A.J. Genomics 67:188-200(2000) [PubMed: 10903844] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, ALTERNATIVE SPLICING (ISOFORMS 2; 3; 4 AND 5), VARIANT PHE-614. |
| [2] | "Genome-wide discovery and analysis of human seven transmembrane helix receptor genes." Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S., Tsutsumi S., Aburatani H., Asai K., Akiyama Y. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed: 15057824] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT PHE-614. |
| [4] | "Proteolytic cleavage of the EMR2 receptor requires both the extracellular stalk and the GPS motif." Chang G.-W., Stacey M., Kwakkenbos M.J., Hamann J., Gordon S., Lin H.-H. FEBS Lett. 547:145-150(2003) [PubMed: 12860403] [Abstract] Cited for: PROTEIN SEQUENCE OF 518-527, PROTEOLYTIC PROCESSING, MUTAGENESIS OF SER-518. |
| [5] | "The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans." Stacey M., Chang G.-W., Davies J.Q., Kwakkenbos M.J., Sanderson R.D., Hamann J., Gordon S., Lin H.-H. Blood 102:2916-2924(2003) [PubMed: 12829604] [Abstract] Cited for: INTERACTION WITH CHONDROITIN SULFATE. |
| [6] | "The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells." Kwakkenbos M.J., Chang G.-W., Lin H.-H., Pouwels W., de Jong E.C., van Lier R.A.W., Gordon S., Hamann J. J. Leukoc. Biol. 71:854-862(2002) [PubMed: 11994511] [Abstract] Cited for: CHARACTERIZATION, TISSUE SPECIFICITY. |
| [7] | "Autocatalytic cleavage of the EMR2 receptor occurs at a conserved G protein-coupled receptor proteolytic site motif." Lin H.H., Chang G.W., Davies J.Q., Stacey M., Harris J., Gordon S. J. Biol. Chem. 279:31823-31832(2004) [PubMed: 15150276] [Abstract] Cited for: AUTOPROTEOLYTIC CLEAVAGE, SUBUNIT. |
| [8] | "Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55." Abbott R.J., Spendlove I., Roversi P., Fitzgibbon H., Knott V., Teriete P., McDonnell J.M., Handford P.A., Lea S.M. J. Biol. Chem. 282:22023-22032(2007) [PubMed: 17449467] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-152, CALCIUM-BINDING, DISULFIDE BONDS. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF114491 mRNA. Translation: AAF21974.1. AB065931 Genomic DNA. Translation: BAC06146.1. Sequence problems. AC004262 Genomic DNA. Translation: AAC05172.1. AC005327 Genomic DNA. No translation available. AC090427 Genomic DNA. No translation available. | ||||||||||||||||||||||||
| IPI | IPI00183280. IPI00183838. IPI00296277. IPI00375382. IPI00549702. | ||||||||||||||||||||||||
| RefSeq | NP_038475.2. NM_013447.2. NP_690880.1. NM_152916.1. NP_690881.1. NM_152917.1. NP_690882.1. NM_152918.1. NP_690883.1. NM_152919.1. NP_690884.1. NM_152920.1. NP_690885.1. NM_152921.1. | ||||||||||||||||||||||||
| UniGene | Hs.531619. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | Q9UHX3. | ||||||||||||||||||||||||
| SMR | Q9UHX3. Positions 28-260. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| STRING | Q9UHX3. | ||||||||||||||||||||||||
Protein family/group databases | |||||||||||||||||||||||||
| MEROPS | S63.001. | ||||||||||||||||||||||||
| GPCRDB | Search... | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 108935835. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | Q9UHX3. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000315576; ENSP00000319883; ENSG00000127507. | ||||||||||||||||||||||||
| GeneID | 30817. | ||||||||||||||||||||||||
| KEGG | hsa:30817. | ||||||||||||||||||||||||
| UCSC | uc002mzp.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 30817. | ||||||||||||||||||||||||
| GeneCards | GC19M014844. | ||||||||||||||||||||||||
| H-InvDB | HIX0014843. | ||||||||||||||||||||||||
| HGNC | HGNC:3337. EMR2. | ||||||||||||||||||||||||
| MIM | 606100. gene. | ||||||||||||||||||||||||
| neXtProt | NX_Q9UHX3. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| GeneTree | ENSGT00600000084176. | ||||||||||||||||||||||||
| HOGENOM | HBG506068. | ||||||||||||||||||||||||
| HOVERGEN | HBG048917. | ||||||||||||||||||||||||
| InParanoid | Q9UHX3. | ||||||||||||||||||||||||
| PhylomeDB | Q9UHX3. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q9UHX3. | ||||||||||||||||||||||||
| Bgee | Q9UHX3. | ||||||||||||||||||||||||
| CleanEx | HS_EMR2. | ||||||||||||||||||||||||
| Genevestigator | Q9UHX3. | ||||||||||||||||||||||||
| GermOnline | ENSG00000127507. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR001881. EGF-like_Ca-bd. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR000742. EGF_3. IPR018097. EGF_Ca-bd_CS. IPR017981. GPCR_2-like. IPR003056. GPCR_2_CD97. IPR000832. GPCR_2_secretin-like. IPR017983. GPCR_2_secretin-like_CS. IPR000203. GPS_dom. [Graphical view] | ||||||||||||||||||||||||
| KO | K08443. | ||||||||||||||||||||||||
| Pfam | PF00002. 7tm_2. 1 hit. PF07645. EGF_CA. 4 hits. PF01825. GPS. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR01278. CD97PROTEIN. PR00249. GPCRSECRETIN. | ||||||||||||||||||||||||
| SMART | SM00179. EGF_CA. 4 hits. SM00303. GPS. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS00010. ASX_HYDROXYL. 4 hits. PS00022. EGF_1. False negative. PS01186. EGF_2. False negative. PS50026. EGF_3. 4 hits. PS01187. EGF_CA. 4 hits. PS00650. G_PROTEIN_RECEP_F2_2. 1 hit. PS50261. G_PROTEIN_RECEP_F2_4. 1 hit. PS50221. GPS. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| NextBio | 52882. | ||||||||||||||||||||||||
| PMAP-CutDB | Q9UHX3. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | EMR2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UHX3 Secondary accession number(s): E9PBR1 Q9Y4B1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with